WHWK: Whitehawk Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Whitehawk Therapeutics Inc (WHWK).

OverviewDividends

$77.76M Market Cap.

As of 08/09/2025 5:00 PM ET (MRY) • Disclaimer

WHWK Market Cap. (MRY)


WHWK Shares Outstanding (MRY)


WHWK Assets (MRY)


Total Assets

$70.32M

Total Liabilities

$17.84M

Total Investments

$18.57M

WHWK Income (MRY)


Revenue

$25.98M

Net Income

-$63.69M

Operating Expense

$90.42M

WHWK Cash Flow (MRY)


CF Operations

-$59.55M

CF Investing

$25.20M

CF Financing

$130.00K

WHWK Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$70,319,000 (-46.90%)

$132,423,000 (-28.12%)

$184,237,000 (16.67%)

$157,910,000 (738.83%)

Assets Current

$61,287,000 (-50.81%)

$124,586,000 (-30.80%)

$180,029,000 (19.01%)

$151,272,000 (709.59%)

Assets Non-Current

$9,032,000 (15.25%)

$7,837,000 (86.24%)

$4,208,000 (-36.61%)

$6,638,000 (4641.43%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$3,811,000 (0%)

Shareholders Equity

$52,478,000 (-50.11%)

$105,195,000 (-33.58%)

$158,378,000 (16.11%)

$136,406,000 (1197.22%)

Property Plant & Equipment Net

$7,633,000 (27.83%)

$5,971,000 (194.14%)

$2,030,000 (230.62%)

$614,000 (338.57%)

Cash & Equivalents

$28,670,000 (-54.41%)

$62,888,000 (61.17%)

$39,019,000 (-73.81%)

$148,989,000 (3244.31%)

Accumulated Other Comprehensive Income

$16,000 (-40.74%)

$27,000 (123.48%)

-$115,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$18,567,000 (-59.60%)

$45,957,000 (-65.59%)

$133,541,000 (0%)

$0 (0%)

Investments Current

$18,567,000 (-59.60%)

$45,957,000 (-65.59%)

$133,541,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$5,311,000 (-17.36%)

$6,427,000 (245.35%)

$1,861,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$5,903,000 (7.56%)

$5,488,000 (194.74%)

$1,862,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,159,000 (-63.39%)

$5,898,000 (-36.42%)

$9,276,000 (-23.94%)

$12,196,000 (-27.00%)

Accumulated Retained Earnings (Deficit)

-$332,654,000 (-23.68%)

-$268,963,000 (-32.36%)

-$203,198,000 (-42.41%)

-$142,685,000 (-337.75%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$833,000 (-34.25%)

$1,267,000 (-23.72%)

$1,661,000 (174.55%)

$605,000 (-94.10%)

Debt Current

$268,000 (-38.25%)

$434,000 (10.15%)

$394,000 (200.76%)

$131,000 (-98.57%)

Debt Non-Current

$565,000 (-32.17%)

$833,000 (-34.25%)

$1,267,000 (167.30%)

$474,000 (-56.99%)

Total Liabilities

$17,841,000 (-34.48%)

$27,228,000 (5.29%)

$25,859,000 (20.25%)

$21,504,000 (-31.20%)

Liabilities Current

$17,074,000 (-35.31%)

$26,395,000 (40.14%)

$18,835,000 (23.32%)

$15,273,000 (-49.19%)

Liabilities Non-Current

$767,000 (-7.92%)

$833,000 (-88.14%)

$7,024,000 (12.73%)

$6,231,000 (419.68%)

WHWK Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$25,983,000 (6.69%)

$24,354,000 (60.06%)

$15,216,000 (1258.57%)

$1,120,000 (-92.32%)

Cost of Revenue

$3,024,000 (7.65%)

$2,809,000 (110.41%)

$1,335,000 (0%)

$0 (0%)

Selling General & Administrative Expense

$36,749,000 (-17.51%)

$44,549,000 (10.88%)

$40,176,000 (117.04%)

$18,511,000 (772.75%)

Research & Development Expense

$51,030,000 (4.29%)

$48,929,000 (49.80%)

$32,662,000 (66.05%)

$19,670,000 (31.06%)

Operating Expenses

$90,417,000 (-3.27%)

$93,478,000 (22.09%)

$76,562,000 (-31.85%)

$112,337,000 (555.83%)

Interest Expense

$154,000 (-33.33%)

$231,000 (0.43%)

$230,000 (-65.41%)

$665,000 (-18.40%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$2,000 (0.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$63,691,000 (3.15%)

-$65,765,000 (-8.68%)

-$60,513,000 (45.03%)

-$110,090,000 (-3065.32%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$63,691,000 (3.15%)

-$65,765,000 (-8.68%)

-$60,513,000 (45.03%)

-$110,090,000 (-3065.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$647,000 (-34.45%)

Net Income Common Stock

-$63,691,000 (3.15%)

-$65,765,000 (-8.68%)

-$60,513,000 (45.35%)

-$110,737,000 (-2380.11%)

Weighted Average Shares

$27,029,942 (0.42%)

$26,917,967 (19.58%)

$22,511,237 (152.27%)

$8,923,369 (250.99%)

Weighted Average Shares Diluted

$27,029,942 (0.42%)

$26,917,967 (19.58%)

$22,511,237 (152.27%)

$8,923,369 (250.99%)

Earning Before Interest & Taxes (EBIT)

-$63,537,000 (3.05%)

-$65,534,000 (-8.71%)

-$60,283,000 (44.91%)

-$109,423,000 (-4012.10%)

Gross Profit

$22,959,000 (6.56%)

$21,545,000 (55.21%)

$13,881,000 (1139.38%)

$1,120,000 (-92.32%)

Operating Income

-$67,458,000 (6.22%)

-$71,933,000 (-14.76%)

-$62,681,000 (43.64%)

-$111,217,000 (-4263.16%)

WHWK Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$25,202,000 (-69.71%)

$83,206,000 (162.61%)

-$132,886,000 (-628.31%)

$25,153,000 (0%)

Net Cash Flow from Financing

$130,000 (-60.12%)

$326,000 (-99.55%)

$72,620,000 (-48.79%)

$141,804,000 (11776.38%)

Net Cash Flow from Operations

-$59,550,000 (0.19%)

-$59,663,000 (-20.19%)

-$49,640,000 (-121.38%)

-$22,423,000 (-76.55%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$34,218,000 (-243.36%)

$23,869,000 (121.72%)

-$109,906,000 (-176.04%)

$144,534,000 (1356.05%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$25,199,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$26,856,000 (-69.19%)

$87,178,000 (165.82%)

-$132,442,000 (0%)

$0 (0%)

Capital Expenditure

-$1,654,000 (58.36%)

-$3,972,000 (-794.59%)

-$444,000 (-865.22%)

-$46,000 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$146,000 (-69.96%)

$486,000 (-99.34%)

$73,279,000 (-52.98%)

$155,833,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

-$4,412,000 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$10,839,000 (-9.33%)

$11,954,000 (23.97%)

$9,643,000 (357.88%)

$2,106,000 (1415.11%)

Depreciation Amortization & Accretion

$653,000 (3.65%)

$630,000 (16.45%)

$541,000 (96.01%)

$276,000 (56.82%)

WHWK Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

88.40% (-0.11%)

88.50% (-2.96%)

91.20% (-8.80%)

100.00% (0.00%)

Profit Margin

-245.10% (9.22%)

-270.00% (32.11%)

-397.70% (95.98%)

-9887.20% (-32211.11%)

EBITDA Margin

-242.00% (9.19%)

-266.50% (32.12%)

-392.60% (95.97%)

-9745.30% (-57225.29%)

Return on Average Equity (ROAE)

-87.70% (-67.05%)

-52.50% (-21.53%)

-43.20% (64.73%)

-122.50% (-656.17%)

Return on Average Assets (ROAA)

-69.10% (-55.98%)

-44.30% (-18.77%)

-37.30% (65.87%)

-109.30% (-818.49%)

Return on Sales (ROS)

-244.50% (9.14%)

-269.10% (32.08%)

-396.20% (95.94%)

-9769.90% (-53287.43%)

Return on Invested Capital (ROIC)

-176.90% (-94.40%)

-91.00% (36.59%)

-143.50% (-106.09%)

2357.90% (1868.20%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.34 (-61.47%)

-0.83 (82.64%)

-4.77 (-145.12%)

-1.95 (76.70%)

Price to Sales Ratio (P/S)

3.28 (46.98%)

2.23 (-88.24%)

18.98 (-90.14%)

192.41 (7407.22%)

Price to Book Ratio (P/B)

1.48 (214.65%)

0.47 (-76.16%)

1.98 (-46.58%)

3.7 (199.60%)

Debt to Equity Ratio (D/E)

0.34 (31.27%)

0.26 (58.90%)

0.16 (3.16%)

0.16 (106.28%)

Earnings Per Share (EPS)

-2.36 (3.28%)

-2.44 (9.29%)

-2.69 (78.32%)

-12.41 (-605.11%)

Sales Per Share (SPS)

0.96 (6.19%)

0.91 (33.88%)

0.68 (436.51%)

0.13 (-97.80%)

Free Cash Flow Per Share (FCFPS)

-2.26 (4.23%)

-2.36 (-6.25%)

-2.23 (11.64%)

-2.52 (49.60%)

Book Value Per Share (BVPS)

1.94 (-50.33%)

3.91 (-44.46%)

7.04 (-53.97%)

15.29 (412.60%)

Tangible Assets Book Value Per Share (TABVPS)

2.6 (-47.11%)

4.92 (-39.88%)

8.18 (-52.61%)

17.27 (133.21%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-3 (0.00%)

-3 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.77 (-377.54%)

0.28 (109.17%)

-3.01 (4.41%)

-3.15 (-853.59%)

Asset Turnover

0.28 (71.95%)

0.16 (74.47%)

0.09 (754.55%)

0.01 (-97.17%)

Current Ratio

3.59 (-23.96%)

4.72 (-50.62%)

9.56 (-3.50%)

9.9 (1492.44%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$61,204,000 (3.82%)

-$63,635,000 (-27.06%)

-$50,084,000 (-122.90%)

-$22,469,000 (-76.91%)

Enterprise Value (EV)

$48,171,522 (369.24%)

-$17,891,763 (-109.95%)

$179,895,351 (-47.68%)

$343,828,800 (33231.41%)

Earnings Before Tax (EBT)

-$63,691,000 (3.15%)

-$65,765,000 (-8.68%)

-$60,513,000 (45.03%)

-$110,088,000 (-3067.09%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$62,884,000 (3.11%)

-$64,904,000 (-8.64%)

-$59,742,000 (45.26%)

-$109,147,000 (-4292.23%)

Invested Capital

$25,408,000 (-42.78%)

$44,407,000 (-65.32%)

$128,044,000 (1439.65%)

-$9,558,000 (-75.96%)

Working Capital

$44,213,000 (-54.97%)

$98,191,000 (-39.09%)

$161,194,000 (18.53%)

$135,999,000 (1295.81%)

Tangible Asset Value

$70,319,000 (-46.90%)

$132,423,000 (-28.12%)

$184,237,000 (19.56%)

$154,099,000 (718.59%)

Market Capitalization

$77,762,522 (56.96%)

$49,542,237 (-84.17%)

$312,989,351 (-37.97%)

$504,590,800 (992.91%)

Average Equity

$72,649,250 (-41.97%)

$125,199,000 (-10.71%)

$140,211,000 (55.11%)

$90,394,777 (227.24%)

Average Assets

$92,177,500 (-37.92%)

$148,491,000 (-8.52%)

$162,323,750 (60.21%)

$101,316,851 (170.05%)

Invested Capital Average

$35,918,250 (-50.13%)

$72,020,750 (71.44%)

$42,009,250 (1005.25%)

-$4,640,603 (-108.88%)

Shares

24,647,392 (0.50%)

24,525,860 (0.54%)

24,395,117 (16.76%)

20,894,029 (565.25%)